BackNervGen Pharma Common stock Overview

NervGen Pharma Common stock Inventory

Track NervGen Pharma Common stock's inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

NervGen Pharma Common stock Inventory History

Loading

NervGen Pharma Common stock vs. peers: Inventory Comparison

Loading

NervGen Pharma Common stock Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NervGen Pharma Common stock (NGEN) FAQ

NervGen Pharma Common stock (NGEN) currently reports a inventory of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore NervGen Pharma Common stock's inventory history and peer comparisons.

NervGen Pharma Common stock's inventory changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NervGen Pharma Common stock reported $0 in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NervGen Pharma Common stock, and consider following NGEN for alerts when major investors trade the stock.

NervGen Pharma Common stock is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NGEN with unrelated industries.